1-(3-astatobenzyl)guanidine has been researched along with astatine in 8 studies
| Studies (1-(3-astatobenzyl)guanidine) | Trials (1-(3-astatobenzyl)guanidine) | Recent Studies (post-2010) (1-(3-astatobenzyl)guanidine) | Studies (astatine) | Trials (astatine) | Recent Studies (post-2010) (astatine) |
|---|---|---|---|---|---|
| 11 | 0 | 2 | 327 | 1 | 91 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (75.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Strickland, DK; Vaidyanathan, G; Zalutsky, MR | 1 |
| Friedman, HS; Strickland, DK; Vaidyanathan, G; Zalutsky, MR | 1 |
| Friedman, HS; Keir, ST; Vaidyanathan, G; Zalutsky, MR | 1 |
| Larsen, RH; Vaidyanathan, G; Zalutsky, MR; Zhao, XG | 1 |
| Cunningham, SH; Mairs, RJ; Vaidyanathan, G; Welsh, PC; Wheldon, TE; Zalutsky, MR | 1 |
| Boyd, M; Mairs, RJ; Wheldon, TE | 1 |
| Higashi, T; Ishioka, NS; Ito, YM; Nagatsu, K; Ohshima, Y; Sakashita, T; Sudo, H; Tsuji, AB; Watanabe, S; Yoshinaga, K | 1 |
| Higashi, T | 1 |
8 other study(ies) available for 1-(3-astatobenzyl)guanidine and astatine
| Article | Year |
|---|---|
Meta-[211At]astatobenzylguanidine: further evaluation of a potential therapeutic agent.
Topics: 3-Iodobenzylguanidine; Animals; Antineoplastic Agents; Astatine; Biological Transport; Guanidines; Humans; In Vitro Techniques; Iodobenzenes; Mice; Mice, Inbred BALB C; Reserpine; Tetrabenazine; Tissue Distribution; Tumor Cells, Cultured | 1994 |
Meta-[131I]iodobenzylguanidine uptake and meta-[211At]astatobenzylguanidine treatment in human medulloblastoma cell lines.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Astatine; Biological Transport; Cell Line; Cell Survival; Cerebellar Neoplasms; Guanidines; Humans; Iodine Radioisotopes; Iodobenzenes; Kinetics; Medulloblastoma; Neuroblastoma; Tumor Cells, Cultured | 1995 |
Evaluation of meta-[211At]astatobenzylguanidine in an athymic mouse human neuroblastoma xenograft model.
Topics: 3-Iodobenzylguanidine; Animals; Antineoplastic Agents; Astatine; Disease Models, Animal; Female; Guanidines; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neuroblastoma; Tissue Distribution; Transplantation, Heterologous; Tumor Cells, Cultured | 1996 |
3-[211At]astato-4-fluorobenzylguanidine: a potential therapeutic agent with prolonged retention by neuroblastoma cells.
Topics: 3-Iodobenzylguanidine; Animals; Antineoplastic Agents; Astatine; Binding Sites; Guanidines; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Mice; Mice, Inbred BALB C; Neuroblastoma; Tissue Distribution; Tumor Cells, Cultured | 1997 |
Toxicity to neuroblastoma cells and spheroids of benzylguanidine conjugated to radionuclides with short-range emissions.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Astatine; Combined Modality Therapy; Guanidines; Humans; Iodine Radioisotopes; Neuroblastoma; Sodium Iodide; Spheroids, Cellular; Tumor Cells, Cultured | 1998 |
Genetic enhancement of radionuclide cancer therapy.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Astatine; Carrier Proteins; Genetic Therapy; Guanidines; Humans; Neoplasms; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Radioisotopes; Radiopharmaceuticals; Symporters; Transfection | 1999 |
Antitumor effects of radionuclide treatment using α-emitting meta-
Topics: Animals; Astatine; Guanidines; Iodine Radioisotopes; Mice; Pheochromocytoma; Rats; Tumor Cells, Cultured | 2018 |
[Research and Development of 211At-MABG, 225Ac Production, and Anti-Podoplanin Antibody Therapy in Japan].
Topics: Actinium; Astatine; Guanidines; Humans; Japan; Research | 2022 |